A new study has found that to escape a drug called lenacapavir, HIV has to damage one of its own components, the capsid. The finding reaffirmed the belief that the viral capsid is a good drug target and that the virus can’t afford to change it too much, opening the door to a new generation of drugs
Source:
www.thehindu.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
